| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |